No evidence for differential methylation of α-synuclein in leukocyte DNA of Parkinson's disease patients
✍ Scribed by Julia Richter; Silke Appenzeller; Ole Ammerpohl; G. Deuschl; Steffen Paschen; Norbert Brüggemann; Christine Klein; Gregor Kuhlenbäumer
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 199 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
This study was supported by funds from the ''Fakult€ atsu ¨bergreifende Forschungsf€ orderung des Medizin-Ausschusses beider Medizinischer Fakult€ aten in Kiel und Lu ¨beck.'' Relevant conflicts of interest/financial disclosures: G. Deuschl, Gregor Kuhlenb€ aumer, and Silke Appenzeller are members of the cluster of excellence ''Inflammation at Interfaces.'' Full financial disclosures and author roles may be found in the online version of this article.
📜 SIMILAR VOLUMES
## Abstract Missense mutations of the α‐synuclein gene have been reported to explain a few kindreds with autosomal dominant Parkinson's disease (PD). In order to identify mutations in our PD patients, we have screened the coding region and 5′flanking region of the gene. DNA samples from 50 patients
also be involved in the pathogenesis of neurodegenerative disorders such as PD. Most strikingly, there are strong in vitro data suggesting that copper interacts with ␣-synuclein, which is thought to play a key role in the pathogenesis of PD. 2 Therefore, we examined the prevalence of the most freque
Patients in the early stages of Parkinson's disease have been shown to walk slower with smaller steps, resembling the gait of normal elderly subjects, but specific disorders of dynamic equilibrium or rhythmic gait patterning have not yet been identified. In the present study, gait control in 22 heal